NewAmsterdam Pharma Company NV OverviewNewAmsterdam Pharma Company NV Net Income
Profitability analysis for NAMS.
Quarterly Net Income
-$48.44M
↓ 22.55% YoY
As of Mar 2026
Annual Net Income (TTM)
-$212.73M
↓ 61.52% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...